Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to stretch out money

.Turnstone Biologics is actually reducing its own head count through 60% and agitating its C-suite i...

Gilead loses hope on $15M MASH wager after reviewing preclinical records

.In a year that has actually observed an approval as well as a boating of readouts for metabolic dys...

Texas biotech axes cancer contract, pins wishes on being overweight

.Alaunos Therapeutics is actually axing an agreement with Precigen, losing hope licensing civil righ...

Capricor reveals more records for DMD treatment after triggering BLA

.Capricor Therapeutics is taking a success tour for their period 2 Duchenne muscular dystrophy (DMD)...

FDA spots Kezar lupus test in grip observing 4 patient fatalities

.The FDA has positioned Kezar Life Sciences' lupus trial on grip after the biotech flagged four deat...

Phase 3 Academic Stone test reaches SMA goal, sending stockpile 200%

.A phase 3 test of Historian Rock's spinal muscular degeneration (SMA) applicant has actually attack...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream point out $182M plan

.RNA biotech CAMP4 Rehabs has marked out think about a $67 thousand IPO, along with inflammation-foc...

Galecto purchases leukemia medicine, drops bone tissue cancer cells asset in pivot

.A year after the failure of an idiopathic pulmonary fibrosis applicant delivered Galecto on a look ...

Judo throws down $100M to knock out renal disease

.Taking the mat is Judo Bio, a promising biotech armed along with $one hundred million to create oli...

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has actually settled CSPC Drug Group $100 million for a preclinical cardiovascular dise...